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A new bone augmenting material is reported which is formed from calcium-
loaded hydrogel-based spheres. On immersion of these spheres in a physiological 
medium, they become surrounded with a sheath of precipitate, which ruptures due to a 
build-up in osmotic pressure, resulting in the formation of mineral tubes that protrude 
from the sphere surface. When brought into close contact with one another, these 
spheres become fused through the entanglement and subsequent interstitial 
mineralisation of the mineral tubules.  The tubular calcium phosphate induces the 
expression of osteogenic genes (RUNX2, SP7, COL1A1 and BGLAP) and promotes 
the formation of mineral nodules in pre-osteoblast cultures comparable to an apatitic 
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calcium phosphate phase. Furthermore, ALP is significantly upregulated in the 
presence of tubular materials after 10 days in culture compared to control groups 
(p<0.001) and sintered apatite (p<0.05). This is the first report of a bioceramic 
material that is formed in its entirety in situ and is therefore likely to provide a better 
proxy for biological mineral than other existing synthetic alternatives to bone grafts. 
 
On immersion of calcium containing hydrogel-based spheres in phosphate rich 
physiological media, a sheath of precipitate forms around the spheres, which ruptures 
due to an increase in osmotic pressure. This release of pressure drives the formation 
of biologically analogous tubular mineral from the gel surface. When spheres are in 
close proximity to one another, a mechanism of hardening is facilitated by mineral 
tubules become intermeshed, which ultimately causes the spheres to fuse. Formation 
of the calcium-loaded spheres and their capacity to fill an ex vivo defect in retrieved 
human bone is reported, in addition to the morphology, structure and composition of 
the precipitated mineral phase.  
A range of synthetic materials have been developed that are capable of filling 
hard tissue defects to overcome the issues that are often associated with autologous 
tissue harvesting, such as local tissue morbidity and lack of availability.[1-2] In 
particular, there have been many ceramic-based materials used for hard tissue 
augmentation. Calcium phosphate and calcium sulphate-based products are available 
commercially, but are yet to replace autograft as the so-called “gold-standard”.[3-4] 
The ceramic materials used for the augmentation of hard tissues are often produced 
using high-temperature treatment processes, meaning that they are of high-
crystallinity and relatively low specific surface area.[5-7] Consequently, synthetic 
ceramic bone replacements often bear little resemblance to native bone mineral, 
which is predominantly nanocrystalline hydroxyapatite (HA, Ca5(PO4)3OH) that is 
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poorly crystalline.[8] Even in the case of cements, which harden through re-
precipitation in the body, much of the hardened structure is formed in the presence of 
excess micro crystalline reactant.[9-10] Moreover, conventional regenerative materials 
are absent of channels to support the penetration of surrounding vascular networks.[11-
12] The level of structuring that is possible with synthetic alternatives to bone graft is 
limited to the production of biomimetic corals and sponge-like structures that provide 
an interporous network for bone regeneration, but replicate none of the 
microstructural organisation of hard tissue at the osteonal level.[13-15] Hard tissues 
exhibit precisely defined hierarchical architectures, with organisation from the 
molecular level through to the macroscale. It is this well preserved architecture that is 
critical to the extraordinary mechanical performance of bone – which is stronger and 
tougher per unit weight than steel.[13] Adopting bioinspired approaches to design 
biomaterials may further enable the generation of regenerative materials with 
advanced capabilities of function and cellular interaction.[16-17] 
One preserved feature of hard tissue is the presence of intricate tubular 
networks, such as canaliculi, Haversian canals and Volkman’s canals found in mature 
bone, as well as dentinal tubules within teeth, that are critical to the function of such 
tissues.[18-20] Tubular channels like these are essential for transporting chemicals, 
gases and nutrients in order to maintain the viability of cells cocooned within 
typically dense mineralised tissue. Mimicking the natural structural features of bone is 
a major challenge but one that is subject to substantial research effort. A prerequisite 
to facilitating the development of vascular networks throughout hard tissue scaffolds 
may be the provision of tubular structures similar in nature to those found in 
mineralised tissues. It has been shown that mineralised tubular frameworks provide an 
ideal framework to mediate revascularisation of bone in vivo.[21]  
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Mineral tubes similar to those found in bone and teeth may be formed using a 
system that is analogous to a chemical garden, where hollow tubular precipitates form 
at the interface between a cationic seed crystal and an anionic solution.[22-23] These 
structures have been likened to a range of tubular minerals found throughout 
nature.[24-25] Surprisingly, there is relatively little work that examines the use of such 
systems for biotechnology applications despite the fact that they have been shown to 
support the entrapment and growth of cells.[26-27] With the exception of calcium 
silicates, phosphates and carbonates, the majority of salts traditionally generated in 
chemical gardens would not be compatible with implantation into the body, including 
but not limited to cobalt, copper, iron, manganese and nickel compounds.[22-24, 26, 28] 
There has recently been work that has shown it is possible to produce biologically 
relevant calcium phosphate structures at the interface between a cation loaded 
hydrogel and anionic solution.[29-32] Indeed, we recently reported on the formation of 
tubular calcium phosphate that resembles tubular architectures found in bone both 
structurally and compositionally.[32] The generation of these structures results from 
the exposure of calcium loaded agarose layered with a phosphate rich solution, which 
ultimately produces a forest of hollow white precipitate tubes (Figure 1A). Initially, a 
precipitate is formed at the gel-liquid interface, which impedes dissolution and creates 
an osmotic pressure. When the osmotic pressure causes localised rupture of the 
precipitate layer, calcium ions are able to diffuse into the liquid phases where a 
tubular calcium phosphate based precipitate forms.[32-33] Growth of these tubes is 
maintained through cyclic build-ups in osmotic pressure and release, which drives 
calcium ions through the established tubule to the tip where it ruptures and a new 
section of tubule is formed.[32-33] The mineral from which these tubules are formed is 
of low crystallinity calcium phosphate, similar to that found in the body.  
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The tubular precipitate did not only form on planar surfaces, but also formed 
when spheres of hydrogel loaded with a 1M calcium nitrate solution were placed into 
a 0.5 M phosphate augmented physiological solution. The spheres were produced 
through the drop-wise addition of hot (80 - 90oC) calcium-loaded agarose gel mixture 
through a 2 mm wide pipette aperture into a reservoir of liquid nitrogen (Figure 1B). 
Upon contact with the liquid nitrogen, the gel droplets quickly solidify as spheres 
through the inverse Leidenfrost effect.[34] The resulting particles were of average 
diameter 3.7 ± 0.4 mm (mean of n=10 ± SD).  The use of this method of manufacture 
meant that we were able to produce spherical agarose particles that were loaded with 
relatively high concentrations of calcium ions (>1 M), which would be very difficult 
to achieve using standard processing methods or if soaking pre-formed spheres in 
cation containing solutions.[35] Agarose was selected as the soft material of choice as a 
consequence of its neutral charge, meaning that it does not impede diffusion of the 
calcium ions. Others have reported the use of mineralised hydrogel, including 
agarose-based systems, for bone augmentation.[36-40] The novelty of the system 
described in this paper is the ability to generate biologically analogous calcium 
phosphate structures that aid in hardening an osteogenic bone graft material in situ. 
When the calcium loaded spheres were immersed in phosphate solutions, 
tubules precipitated around the periphery of the particles but grow preferentially 
upward due to buoyancy effects (Figure 1C).[23] Altering the metal and reactive 
counter ion concentrations directly influences the kinetic driving forces of tubular 
self-assembly, including osmotic, diffusion and pH gradients that exist within the 
material system. This influences the gross morphology of the tubes and can also be 
used to adjust formation rate. Increasing phosphate solution concentration from 500 
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mM to 1 M allows control over mineral tubular growth rate between 0.3 mm/min (18 
mm/hr) to 0.5 mm/min (30 mm/hr) (Figure S1).  
The tubules typically exhibit diameters between 100 and 150 µm, which is 
ideal for ingress of osteogenic cells (Figure 1D).[41] Additionally, these channels 
facilitate mass transport of ionic solute during structure formation, similar to how 
osteon structures direct the flow of blood within Haversian systems in order to 
exchange nutrients and gases. They also exhibit a hierarchical bilayer wall structure 
comprised of low crystallinity HA (Ca5(PO4)3OH) and dicalcium phosphate dihydrate 
(DCPD, CaHPO4.2H2O) (Figures 1E and S2). This structure develops inwards as a 
consequence of the contrasting environments inside and outside of the tube resulting 
in a steep concentration gradient of reactive species across the tube wall. This 
ultimately results in a calcium rich inner wall, and phosphate rich outer wall (Figure 
1F).[42] 
Mineralising calcium loaded spheres placed in close contact with one another 
fuse through the formation of precipitate and the development of interweaving tubes 
at their periphery (Figure 2A). The interactions formed between the spheres were of 
sufficient strength to allow for the fusion of multiple spheres to form a larger structure 
(Movie S1). Elemental mapping using micro X-ray fluorescence (µ-XRF) confirmed 
that the particles were united by a calcium phosphate phase (Figure 2B). It was 
possible to assemble the gel spheres into relatively complex geometries, such as the 
pyramid shown in Figure 2C. 3D micro-computed tomography (µ-CT) 
reconstructions of this structure show that mineral coverage (red and green) occurs 
extensively across the surfaces of hydrogel spheres (blue), and even in the centre of 
the structure (Figure 2D). Mechanical properties of hardened cylindrical structures 
(12 mm high by 12 mm wide) were assessed under compressive loading to ascertain 
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the adhesion between the spheres of a mineralised construct. Structures possessed a 
compressive strength of 200 ± 40 kPa (mean of n=3 ± SD). Although the interfacial 
precipitate that develops between spheres is able to support the formation of 
mineralised constructs, subsequent failure of these structures under relatively low 
forces suggests application in the treatment of low load bearing defects, such as that 
of the craniofacial skeleton. Despite the low resistance of mineralised spheres to load, 
within an augmented defect space the integrity of a hardened network of spheres will 
likely be supported by adjacent hard tissue. Furthermore, the strength of the graft may 
be improved over time by the ingress of newly forming bone between spherical 
structures and the integration of tubules with native bone interfaces.   
To demonstrate that this approach could be used for the augmentation of a 
hard tissue defect, a cylindrical defect approximately 10 mm wide and 15 mm deep 
was introduced into an ex vivo human tissue sample, which was then packed with 
calcium loaded spheres (Figure 3A). The filled defect was then placed into a 
phosphate rich medium (1 M phosphate solution) and mineral was observed to form 
rapidly across the surface with the formation of tubes becoming apparent soon 
thereafter. After 24h this structure could be inverted and irrigated with water without 
a loss of mechanical integrity (Movie S2). µ-CT revealed the extent of mineral 
deposition within the defect (Figure 3B). Cross-sectional images show mineral around 
the surface of spheres and tubular structures within the defect, filling the inter 
particulate spaces with a mineral phase. From µ-CT examination, the interfaces 
between the spheres and the mineral deposited are extremely difficult to differentiate 
from the opposing bone. µ-XRF analysis demonstrates that the elemental composition 
of precipitated calcium phosphate mineral is similar to the surrounding tissue, also 
making it difficult to distinguish a clear interface between bone and the spheres. It is 
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likely that compositional similarities between mineral phases aid the bone bonding 
capability of the system at the interface between bone tissue and mineral releasing 
spheres (Figures 3C and S3). 
In order to demonstrate the biocompatibility of tubular precipitate and assess 
its osteoinductive properties, we analysed its capacity to induce osteogenesis within a 
population of murine MC3T3 pre-osteoblasts. Our findings were compared with a 
synthetic hydroxyapatite phase that had undergone a sintering treatment (HA). Similar 
phases are routinely applied as bone grafts, and therefore provided an osteogenic 
control within this study.[5-7]  
The biological response of MC3T3 cells to tubular mineral was examined 
using a transwell culture system in which our calcium phosphate tubes were 
distributed within an insert chamber and the indirect effects monitored. Cell viability 
assessed using Calcein AM/propidium iodide staining demonstrated tubular mineral 
exhibited no adverse cytotoxic effects over a period of 10 days (Figure 4A). This was 
further confirmed by alamar blue, which overall identified comparable levels of 
metabolic activity in line with both positive and negative controls, as well as the HA 
standard (Figure 4B).  
In order to examine the comparative osteoinductive effects of tubes we 
analysed levels of the alkaline phosphatase activity in each culture at 3, 7 and 10 day 
time points (Figure 4C). Levels of ALP generally increased for all treatments over a 
period of 10 days in culture. At day 3, ALP generated by cells in pro-osteogenic 
media and HA groups was significantly increased (p<0.001) compared to negative 
control and Tube groups, albeit at relatively low levels. ALP was found to be 
significantly (p<0.001) upregulated in the positive osteogenic control at day 7 when 
compared with both HA and Tube groups, which is likely related to the availability of 
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free phosphates (exogenous beta-glycerophosphate) for cells to utilise within these 
particular control groups. However, by day 10, ALP activity was significantly 
upregulated in the Tube group compared to both the non-osteogenic control (p<0.001), 
pro-osteogenic control (p<0.001), and sintered HA groups (p<0.05). Detection of 
significantly enhanced levels of ALP in the Tube groups suggests that even in an 
early stage of in vitro culture, tubular calcium phosphate is able to facilitate 
favourable conditions for osteogenic differentiation more so than a HA alternative.  
The relative osteoinductive effects of tubular mineral was further determined 
using quantitative real-time PCR (qRT-PCR) to reveal the expression of genetic 
markers for both immature and mature osteoblasts (Figure 4D). The expression of 
early osteogenic markers RUNX2 and SP7 were in line with the osteogenic control. 
RUNX2 and SP7 were significantly reduced in the Tube group at day 3 when 
compared with HA (p=0.033 and p=0.024 respectively), possibly indicating an earlier 
primary osteogenic response in this culture. The expression of COL1A1 was 
upregulated in all treatments compared with the negative control but not significant 
between treatments, which indicates the rate of ECM deposition is not negatively 
affected following exposure to calcium phosphate tubes. Similarly, levels of the 
mature osteoblast marker BGLAP are comparable between pre-osteoblasts exposed to 
tubular precipitate, HA and the osteogenic control over a period of 10 days in culture. 
Formation of comparable calcified nodules was observed at day 10 in all 
cultures, as shown by alizarin red staining. Nodules formed in the presence of tubes 
were comparable to those observed in the presence of HA (Figure 4E). Collectively, 
these results demonstrate that tubular calcium phosphate mineral generated by 
calcium loaded hydrogel spheres in the present study is biocompatible and exhibits 
osteoinductive profile consistent with a clinically applied calcium phosphate such as 
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sintered HA. Further work will need to conducted to determine the osteoconductive 
topographic effects of the tubular structures to comprehensively define its efficacy as 
a scaffold for hard tissue repair. 
Inspired by processes that are able to mimic the generation of natural tubular 
mineral structures, we have developed a device capable of augmenting a hard tissue 
defect through the production of tubular mineral. The material consists of calcium 
loaded spheres manufactured using a process that allows for the incorporation of high 
concentrations of calcium. Immersion of these spheres in physiologically relevant 
solutions rich in phosphate stimulates tube formation, which means that they could be 
ideal for use in biological environments. Compared with the majority of synthetic 
bone substitutes that are typically dense and highly crystalline, this system enables: 
(1) the formation of tubular calcium phosphate mineral that is structurally and 
compositionally akin to the tubular features found in bone and tooth, providing a 
structured osteogenic scaffold, (2) mineral formation in situ in the absence of 
microcrystalline reactant, facilitating a low-crystallinity product comparable to the 
surrounding hard tissue, and (3) tuneable mineral synthesis by the adjustment of 
precipitation parameters,  enabling physical properties such as fusion time to be 
modified using physiologically relevant conditions, such as phosphate solution 
concentrations. The microscale structural features of the mineral phase may also 
enable better vascularisation of the implant.[21]  
In summary, we present a strategy for directly delivering hierarchical tubular 
mineral into hard tissue defects using spheres of agarose hydrogel loaded with 
calcium. In phosphate solutions, these spherical structures fuse, forming a solid 
through the intermeshing of mineral tubules that are expelled from the surface of the 
soft material.  
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Experimental Section  
Calcium loaded hydrogel fabrication and mineral initiation: Calcium loaded gels 
were made by adding 5 wt% agar powder (for microbiology, Sigma-Aldrich, UK) to 1 
M calcium solutions prepared from calcium nitrate tetrahydrate crystals (99%, ACS 
reagent, Sigma-Aldrich, UK) and distilled water before heating the mixture to 80-
90oC. For conventional set-up, a layer of gel was set in clear cylindrical containers 
and allowed to cool to room temperature. For calcium loaded spheres, warm gel was 
added drop-wise to an insulated chamber of liquid nitrogen. Spheres were collected 
after dissipation of the nitrogen. Mineralisation was initiated upon gel surfaces, 
calcium loaded sphere constructs, and within an ex vivo bone defect using phosphate 
solutions prepared by dissolving crystals of dibasic ammonium phosphate (≥98.0%, 
reagent grade, Sigma-Aldrich, UK) at concentrations between 500 mM and 1 M.  
 
Compressive strength testing of mineralised constructs: Calcium loaded hydrogel 
spheres containing 1M calcium ions were packed into a 12 x 12 mm cylinder. 
Mineralisation was initiated by submerging the constructs in 1 M dibasic ammonium 
phosphate solution, and the hardened structures were recovered after 24 h. 
Mechanical data was collected using a Zwick/Roell Z030 universal tester equipped 
with a 100 N load cell. Compression tests were performed at a speed of 1 mm/min, 
until failure of the specimens. The maximum force to failure was noted and used to 
calculate the compressive strength with Equation 1:  
 
σ = F / A         (Equation 1) 
 
Where: σ = Compressive strength (MPa), F = Force (N), A = Contact area (mm2) 
     
12 
 
Units of compressive strength were subsequently converted from MPa to kPa 
thereafter.  
 
SEM: Samples were placed on an aluminium stub using double-sided sticky carbon 
discs. Gold sputter coating was performed prior to imaging using a K550X sputter 
coater (Quorum Technologies, U.K.). SEM images were then acquired using an EVO 
MA 10 scanning electron microscope (Carl Zeiss AG, Germany).   
 
µ-XRF: Specimens were elementally mapped using an M4 Tornado instrument 
(Bruker, U.S.A.). Measurement settings of 20 ms/pixel over 25 frames in the case of 
Figure 1F, and 2 frames in the case of Figure 2b and 3C, were employed with the 
instrument operating at 50 kV with anode current of 300 mA. During measurements, 
the chamber was maintained at 500 mbar in case of Figure 1E.  
 
Human tissue model: Bone tissue was collected from patients undergoing elective 
knee replacement surgery. The United Kingdom National Research Ethics Service 
(East of Scotland Research Ethics Service) provided ethical approval (11/ES/1044). 
Tissues were washed using phosphate buffered saline (PBS) (calcium and magnesium 
free, Sigma-Aldrich, UK) before defects 10 mm wide and a minimum of 10 mm deep 
were introduced using a surgical drill. Calcium loaded spheres were gently packed 
into defect spaces and self-mineralisation initiated as detailed above.      
 
CT scanning: Samples were transferred to a sealed low X-ray attenuation tube. 
Structures were scanned using a Skyscan1172 microcomputer tomography (µ-CT) 
instrument (Bruker, U.S.A) with 60 kV maximum X-ray energy, 6 W beam power, 
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2000 ms exposure per projection, and 12.44 µm pixel size. Slice data was 
reconstructed using NRecon (Version 1.6.10, Bruker) and visualised 
using CTVox (Version 3.0, Bruker). For self-mineralising sphere pyramid constructs, 
greyscale images were artificially coloured by assigning blue, green, and red transfer 
functions to grey scale ranges matching the calcium loaded spheres (blue) and 
mineralised regions (green and red). For the mineralised human defect model, an 
opacity transfer function was applied to best segment the greyscale range 
corresponding to the tubules from the rest of the structure to render 3D images of 
deposited mineral within the defect.  
 
Synthesis of synthetic hydroxyapatite and sintering procedure: Hydroxyapatite (HA) 
was prepared by sol-gel precipitation following a reported method [43]. For sintering, 
powder was transferred to a heatproof ceramic dish and subjected to 650 oC for 3 h in 
a CWF 1300 furnace (Carbolite, UK). The heating and cooling ramp rate was set at 5 
oC per min, and sintered HA powder (HA) was recovered only after the furnace had 
returned to room temperature.   
 
In vitro cell culture: MC3T3 murine pre-osteoblast cells were purchased from 
America Type Culture Collection (ATCC) and used between passage 4-6. Cells were 
initially cultured in growth medium consisting of alpha-modified Minimum Essential 
Medium (Sigma-Aldrich, UK) supplemented with 10 % FBS, 2.4 % L-glutamine, and 
1% penicillin/streptomycin. Osteogenic medium was further supplemented with 10 
mM beta-glycerophosphate (Sigma-Aldrich, UK), 50 μg/mL L-ascorbic acid (Sigma-
Aldrich, UK) and 10 nM dexamethasone (Sigma-Aldrich, UK). 
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Cell viability: Viability was assessed at day 3 and 10. Cell cultures were immersed in 
1mL growth medium supplemented with 3 μM calcein acetoxymethylester (Calcein 
AM, Life Technologies, UK) and 1 μM propidium iodide (Life Technologies, UK) 
and incubated at 37°C for 5 mins. Cell viability was determined visually using an 
Olympus IX81 fluorescence microscopy (Olympus, USA). 
 
Alamar blue metabolic activity: MC3T3s were seeded at a density of 6.5x103  
cells/cm2 in growth medium and allowed to adhere at 37 °C for a period of 24 hrs. 
Following 24 hrs culture transwell inserts (0.4 μm ThinCert™, Greiner Bio-One, 
Austria) containing 20 mg sintered hydroxyapatite (HA) or 20 mg tubular precipitate 
(Tubes) were incorporated and the total media volume adjusted to 2 mL. Metabolic 
activity was assessed at every 24 hrs over a total period of 5 days by incorporating 
10% Alamar Blue reagent (Life Technologies, UK) into the cell culture medium and 
measuring absorbance at 570nm using a Synergy™ HT microplate reader (Biotek, 
UK). 
 
Alkaline phosphatase (ALP) activity: Cellular alkaline phosphatase activity was 
quantified using the SensoLyte® pNPP Alkaline Phosphatase Assay Kit (AnaSpec, 
USA). MC3T3s were plated in 12 well plates at an initial seeding density of 26x103 
cells/cm2in the presence of 1 mL growth medium. Following 24 hrs culture transwell 
inserts (0.4μm ThinCert™, Greiner Bio-One, Austria) containing 20 mg sintered 
hydroxyapatite (HA) or 20 mg tubular hydroxyapatite (Tubes) were incorporated and 
the total media volume adjusted to 2 mL. ALP activity was measured at 3, 7 and 10 
days according to the manufacturer’s instructions. Briefly, cell monolayers were 
washed twice using 1x assay buffer provided. Cells were detached from the surface of 
the culture plate in the presence of 200 μL permeabilisation buffer using a cell scraper. 
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The resulting cell suspension was collected in a micro centrifuge tube, incubated at 
4°C for 10 mins under agitation, and then centrifuged at 2500 g for 10 mins. 
Supernatant was transferred to a 96 well plate where it was combined with an equal 
volume of pNPP substrate. Absorbance was measured at 405 nm using a Synergy™ 
HT microplate reader (Biotek, UK). ALP activity was normalised to DNA 
concentration (see DNA isolation).  
 
RNA Isolation and quantitative real-time polymerase chain reaction (qRT-PCR): 
Following culture, total RNA was isolated using TRIzol reagent (LifeTechnologies, 
UK); the manufacturer’s instructions were followed. Briefly, TRIzol reagent was used 
to directly lyse cells before chloroform (Sigma Aldrich, UK) was added to separate 
the aqueous RNA phase through centrifugation. The RNA phase was removed and 
isopropanol (Fisher Scientific, UK) was added to precipitate the RNA. The precipitate 
was centrifuged and then washed with ethanol before drying in a vacuum desiccator. 
Finally, the pellet was resuspended in molecular biology grade water (Fisher 
Scientific, UK). RNA concentration and A260/280 ratio were measured using a 
spectrophotometer (NanoDrop 2000, ThermoScientific).  
 QuantiFast one-step master mix (Qiagen) was used to measure mRNA 
expression of RUNX2, SP7, COL1A1, BGLAP and β-actin which was used as a 
housekeeping gene. All primer sequences were designed by KiCqStart and supplied 
by Sigma-Aldrich (Gillingham, UK); forward and reverse sequences are shown in 
Table S1. qRT-PCR was performed using a BioRad CFX384 (BioRad, USA) and 
relative expression was calculated using ddCT, normalised to β-actin. 
 
DNA isolation: DNA was purified from interphase and organic phase components 
collected during RNA isolation following removal of the RNA phase (see RNA 
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Isolation and quantitative real-time polymerase chain reaction (qRT-PCR) of 
methods section). Briefly, 100% ethanol (Fisher Scientific, UK) was to the mixtures 
which were incubated for 3 mins, before centrifugation to pellet the DNA. DNA was 
washed twice by resuspending the pellet in 0.1 M sodium citrate (Sigma Aldrich, UK) 
solution prepared with 90 % molecular grade water and 10 % ethanol, incubating for 
30 mins, and centrifugation at 2000 G for 5 mins at 4 oC. DNA was then resuspended 
in a 75 % ethanol and 25% molecular water solution, incubated for 20 mins before 
being centrifuged, and the pellet air dried for 10 mins following removal of the 
supernatant. Finally, the pellet was resuspended in 8 mM NaOH solution prepared 
with molecular grade water, and the DNA concentration and A260/280 ratio 
measured using a spectrophotometer (NanoDrop 2000, ThermoScientific). ALP 
activity was normalised to the DNA concentration. 
 
Alizarin red calcium staining: Cultures were washed using sterile PBS and 
subsequently fixed with 4% paraformaldehyde for 20 mins at room temperature. 40 
nM alizarin red solution (Sigma-Aldrich, UK), which had been adjusted to pH 4.2 
using ammonium hydroxide was applied to each culture for a period of 20 mins. 
Unbound stain was eluted by successive washes in PBS. Images were captured using 
an INVERSO TC100 inverted microscope (Resolution, UK) at x10 magnification. 
 
Statistical analysis: All statistically analysis was performed using SigmaPlot 13.0 
software. All groups underwent normality testing by Sharpio-Wilk method and equal 
variance testing by Brown-Forsythe method. One-way AVOVA was used to 
determine if statistical differences existed between sample groups at different time 
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points, with alpha level of 0.05. Post-hoc all pairwise multiple comparison tests were 
performed by Holm-Sidak method. Values of p<0.05 were deemed to be significant.  
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Figure 1. (a) Conventional experimental set-up we previously reported (Reference 
32), which produces calcium phosphate tubules that are structurally and 
compositionally similar to microstructures within bone, providing the starting point 
for the work reported herein. (b) Schematic of fabrication method of calcium-loaded 
spheres, involving drop-wise addition of calcium loaded agarose hydrogel into a 
reservoir of liquid nitrogen. (c) Calcium loaded spheres before and after 
mineralisation, showing the ejection of tubular calcium phosphate mineral. (d) SEM 
micrograph showing the tubule microstructure, consisting of a bilayer tubule wall 
surrounding a hollow core. (e) SEM micrograph of tube wall bilayer structuring. (f) 
µ-XRF elemental mapping of a calcium phosphate tubule cross-section (Kα channels 
for calcium (red) and phosphorous (green) shown). 
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Figure 2. (a) Fusion of two calcium loaded spheres in close proximity to one another 
during self-mineralisation. (b) µ-XRF elemental mapping of a calcium loaded sphere 
cross-section before and after inducing self-mineralisation (Kα channels for calcium 
(red) and phosphorous (green) shown) (c) Calcium loaded sphere pyramid construct 
before and after triggering self-mineralisation, leading to complete unification. (d) µ-
CT of calcium loaded sphere pyramid after submersion in phosphate solution. Colour 
scales in-set represent an increase in relative density of material from blue (calcium 
loaded sphere) to green and red (mineral).  
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Figure 3. (a) Schematic of calcium loaded spheres augmenting an ex vivo human 
bone defect, showing an empty bone defect, the packing of spheres to augment the 
defect, and triggering of self-mineralisation with 1 M phosphate solution. (b) µ-CT of 
human hard tissue model containing mineralised calcium loaded spheres that have 
deposited mineral and tubular structures within the defect. (c) µ-XRF elemental 
mapping of a cross-section of the human hard tissue defect (Kα channels for calcium 
(red) and phosphate (green) shown).   
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Figure 4. (a) Fluorescent microscope images of cells stained with Calcein AM and 
propidium iodide, showing viable cells (green) and dead cells (red). MC3T3 cells 
were cultured either in supplemented media (negative control group = -ve) or 
supplemented osteogenic media (positive control group = +ve), and additionally in 
supplemented media in the presence of synthetic HA that had been sintered (HA), as 
well as tubular calcium phosphate (Tubes). For reference, these groups correspond to 
the remaining parts of this figure as indicated. (b) Metabolic activity of MC3T3 cells 
as determined by alamar blue (mean of n=6 ± SD). (c) Determination of ALP 
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produced by MC3T3 cells (mean of n=3 ± SD). (d) Correspending gene expression of 
RUNX2, SP7, COL1A1 and BGLAP determined by qRT-PCR (mean of n=3 ± SD). 
For figure parts b-d, significant difference found by one-way ANOVA and post-hoc 
statisical testing analysis is indicated by *, **, and ***, which correspond to p values 
of p<0.05, p<0.01, and p<0.001 respectively. (e) Optical microscopy of cultures fixed 
and stained with alazarin red showing the formation of comparable mineral nodules 
formng in the presence of osteogenic media, HA and Tube groups after 10 days.  
  
 
 
 
A new bone-filling material based on the delivery of hydrogel-based spheres 
unifies in the presence of biological fluids rich in phosphate through interfacial 
mineral fusion and tubule entanglement that hardens the bone augmentation device. 
The demonstrated augmentation system presents a major first of its kind by 
possessing the capacity to form in its entirety in vivo.  
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Figure S1. Calcium phosphate tubule growth after 2 mins, 15 mins, and 30 mins from 
calcium loaded spheres placed in phosphate solutions at concentrations of 0.5 M, 0.75 
M, and 1 M.  
 
 
Figure S2. Raman spectrum (red) and powder XRD pattern (blue) of tubule 
precipitate harvested at 3 hrs. The compositional make-up of HA and DCPD is 
confirmed by Raman spectroscopy through the identification of stretching and 
bending modes associated with PO43- ions and HPO42- ions, present in the structure of 
HA and DCPD respectively. The predominant crystalline phase constituting tubule 
precipitate was found to be HA, as confirmed by matching to the International Centre 
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for Diffraction Data (ICDD) pattern with number 01-076-0694 (synthetic HA, * 
quality, with formula Ca5(PO4)3(OH)2). Inability to identify DCPD peaks suggests the 
phase exists in an amorphous form. Peak broadening a high noise to signal ratio 
suggests the mineral is of low crystallinity overall; a characteristic also true of 
mammalian bone mineral.  
 
 
 
Figure S3. (a) µ-XRF elemental mapping of a cross-section of the human hard tissue 
defect (Kα channels for calcium (red) and phosphate (green) shown), as presented in 
Figure 3c. µ-XRF spectra were acquired for the total scan points within the referenced 
square areas placed upon areas of mineral. The areas selected account for two areas of 
bone (Areas 1 and 2), a mineral fusion interface between a calcium loaded sphere and 
bone (Area 3), and likewise between two calcium loaded spheres within the defect 
(Area 4). (b) Spectra of highlighted areas for the P Kα signal. (c) Spectra of 
highlighted areas for the Ca Kα signal. Both (b) and (c) show slight variation in Kα 
signal strength, however, there exists a distinct elemental within and about the periphery of the defect volume.   
Gene Forward Reverse 
BGLAP ACCATGAGGACCATCTTTC GGACATGAAGGCTTTGTC 
COL1A1 GCTATCACCAAACTCAGAAG GAAGCAAAGTTTCCTCCAAG 
RUNX2 ACAAGGACAGACTCAGATTAC CAGTGTCATCATCTGAAATACG 
SP7 TGCTTGAGGAAGAAGCTC CTTCTTTGTGCCTCCTTTC 
BACT GATGTATGAAGGCTTTGGTC TGTGCACTTTTCTTGGTCTC 
Table S1. Forward and reverse primer sequences employed for qRT-PCR.  
 
Movie S1. Interaction between calcium loaded spheres in close proximity to one 
another mediated by mineral fusion and tubule entanglement initiated by phosphate 
rich solutions. 
 
Movie S2. Unification of calcium loaded spheres by mineral fusion and tubule 
entanglement within an ex vivo human tissue model after 24 hrs submergence in 
phosphate solution. (It should be noted that this particular defect was over packed 
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with calcium loaded spheres. The intention is to provide a practical exhibition of how 
the material may be clinically applied, particularly highlighting the integrity of the 
fused components.) 
 
 
 
 
